Product Description

The goal of this continuing medical education module is to present the assessment of a patient with suspected breast implant–associated anaplastic large cell lymphoma, the evaluation and diagnosis, the preoperative oncologic workup, the formation and execution of a surgical treatment plan, and the inclusion of adjunct treatments when indicated. In addition, staging and disease progression for treatment of breast implant–associated anaplastic large cell lymphoma are discussed.

Learning Objectives

After viewing this course, the participant should be able to:

1. Describe the diagnostic criteria for breast implant-associated (BIA) anaplastic large cell lymphoma (ALCL). Appropriately evaluate a patient with suspected BIA_ALCL, including appropriate imaging, laboratory tests, and pathologic evaluation.
2. Understand the operative treatment of BIA-ALCL, and indications for systemic chemotherapy and/or radiation therapy in advanced disease.
3. Understand treatment outcomes and prognosis based on stage of disease.

Faculty

Mark W. Clemens, MD; Garry S. Brody, MD; Raman C. Mahabir, MD; Roberto N. Miranda, MD

Plastic and Reconstruction Surgery® Editors:

Editor-in-Chief: Rod J. Rohrich, MD 

Co-Editor: James M. Stuzin, MD 

Section Editor: Donald H. Lalonde, MD

Accreditation Information

Patient Safety Credit: 0.5 

Media: Journal Article, Video 

Publish Date: 4/1/2018

Expiration Date: 4/1/2021

Estimated time to complete this course: 1.0 hour 

Directly provided by the American Society of Plastic Surgeons^® (ASPS^®)

Accreditation Statement

The American Society of Plastic Surgeons (ASPS) is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Designation Statement

The ASPS designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit^TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Intended Audience

This educational activity is intended for plastic surgery practitioners, residents, and other healthcare professionals interested in translating expanded knowledge into practice for the improvement of patient outcomes in plastic and reconstructive surgery.

Disclosures

Dr. Rohrich, MD is the Principal/Co-Principal Investigator of research grants awarded to the University of Texas Southwestern Medical Center, Dallas, from Medicis, Mentor, and Contura Pharmaceutical. All research funds are provided directly to UT Southwestern. Dr. Stuzin has no relevant financial relationships or affiliations to disclose. Dr. Lalonde is a consultant for ASSI Instruments. None of the authors have any relevant financial relationships or affiliations to disclose. All ASPS staff members managing this activity have no relevant financial relationships or affiliations to disclose. All identified conflicts of interest have been resolved and the educational content thoroughly vetted by ASPS for fair balance, scientific objectivity, and appropriateness of patient care recommendations. The ASPS also requires faculty/authors to disclose when off-label/unapproved uses of a product are discussed in a CME activity or included in related materials.

Product Code: 23306